TABLE 2.

Patient characteristics

Patient	Age at start of infection (yr)	Sex	Baseline CD4 count (cells/mm3)	Baseline viral load (copies/ml)	CD4 slope (% change/yr)
P1a	35	Male	555	7,728	−15.7
P2	36	Male	570	4,973	−14.8
P3	40	Male	250	<50	−3.6
P4	34	Male	1,452	293	−7.0
P5b	37	Male	1,102	1,533	−6.4
P6	28	Male	833	10,861	−5.9
P7	34	Male	720	3,370	−7.3
P8	30	Male	522	124,070	−34.0
P9	50	Female	600	44,427	−17.6
P10	31	Male	620	6,070	1.9
P11	48	Male	546	6,876	−19.5
P12	42	Male	468	5,419	−10.4

^aP1 received treatment for 14 months during the study period. Samples during treatment and 6 months after discontinuation were excluded.

^bP5 received treatment for 2 weeks during the study period.